Some patients are surprised when a painful joint feels more uncomfortable shortly after a stem cell injection. Because the purpose of treatment is ultimately to improve symptoms, an early increase in pain can create concern that the injection has caused damage or that the treatment has failed.
Temporary pain, swelling, or stiffness can occur after an intra-articular mesenchymal stem cell injection. Published studies of MSC treatment for knee osteoarthritis consistently report local pain and swelling among the most common short-term adverse reactions. These reactions are generally temporary, while serious complications have been uncommon in controlled clinical studies. However, worsening pain should not automatically be described as a normal “healing reaction.” The severity, timing, associated swelling, warmth, fever, and whether symptoms are improving or worsening all matter.
Why Can Pain Increase After a Stem Cell Injection?
Several factors may contribute to temporary discomfort after a joint injection. The procedure itself involves inserting a needle into or around tissue that may already be inflamed or sensitive. Introducing fluid into a confined joint space can also temporarily increase pressure and produce a sensation of fullness, tightness, or soreness.
A local inflammatory response may also occur after treatment. MSC studies involving intra-articular administration frequently report temporary joint pain, swelling, and effusion following injection. Researchers have documented these reactions with different MSC sources, including umbilical cord derived cells.
The exact cause of post-injection discomfort cannot always be attributed to one factor. It may involve a combination of the injection procedure, temporary joint distension, existing inflammation, and the body’s local response to the administered product.
For this reason, mild post-treatment soreness is different from progressive or severe pain that requires clinical assessment.
How Common Is Pain After Intra-Articular MSC Treatment?
Temporary local reactions are among the more frequently reported side effects of intra-articular MSC therapy. A systematic review examining stem cell based injections for knee osteoarthritis found that transient adverse events occurred in approximately 12% of treated patients overall, with pain and swelling at the injection site being the most commonly reported reactions. Serious complications were uncommon in the studies reviewed.
More recent randomized-trial analyses have reached a similar conclusion. Local injection-site pain and joint swelling appear more frequently after MSC treatment than with some control injections, while serious treatment-related complications remain uncommon.
The important clinical message is not that every patient should expect pain. Many patients experience little discomfort. Rather, a temporary increase in soreness is a recognized possibility after intra-articular treatment.
Does Increased Pain Mean the Stem Cells Are Working?
No. Increased pain should not be used as evidence that stem cells are “activating,” regenerating tissue, or working more effectively.
This is an important misconception in regenerative medicine. A temporary inflammatory response may occur after an injection, but there is no established evidence showing that patients who experience more post-treatment pain achieve better long-term outcomes.
The opposite is also true. A patient who experiences very little soreness should not assume that the treatment was ineffective. Treatment response should be evaluated later using clinically meaningful outcomes such as pain during activity, joint function, mobility, range of motion, and the ability to perform daily activities.
Does More Pain Mean the Treatment Has Failed?
Not necessarily. Early post-injection discomfort and longer-term treatment response are different issues. A temporary increase in pain shortly after treatment does not, by itself, predict whether a patient will eventually experience improvement.
At the same time, worsening symptoms should not simply be ignored. The expected pattern is generally that temporary procedural discomfort stabilizes and then improves rather than becoming progressively more severe.
If pain continues to increase, significantly limits movement, or is accompanied by other concerning symptoms, the treating physician should reassess the joint.
How Can You Tell the Difference Between Expected Soreness and a Complication?
Mild soreness, stiffness, a feeling of pressure, or limited swelling shortly after an intra-articular injection can occur as part of the local post-procedure response.
More concerning symptoms include progressively increasing pain, marked swelling, significant warmth or redness, severe limitation of joint movement, inability to bear weight, or fever.
One important complication that clinicians must consider is septic arthritis, meaning infection inside a joint. Fortunately, infection following properly performed intra-articular procedures is rare, but it is potentially serious and requires prompt treatment. Pain with joint movement, new swelling or effusion, restricted range of motion, and systemic signs of infection may warrant urgent assessment. This is why severe symptoms should not simply be labelled a “stem cell flare.”
Can Swelling Make the Pain Feel Worse?
Yes. Swelling and joint effusion can contribute to temporary pain and stiffness after an injection.
The joint capsule has a limited amount of space. When additional fluid or inflammation increases pressure within the joint, patients may notice tightness or pain when bending or straightening the area.
This is particularly relevant to knee injections, where transient pain and swelling are among the most frequently documented local reactions following MSC administration. Some UC-MSC studies have also reported injection-site pain and swelling without serious treatment-related adverse events. The amount of swelling can vary considerably between patients.
Can the Same Thing Happen After a Shoulder Stem Cell Injection?
Temporary soreness may also occur after injections into other joints, including the shoulder. However, most published MSC safety data currently come from knee osteoarthritis studies, so evidence should not automatically be generalized to every anatomical site.
The underlying principle is similar: inserting a needle and fluid into an already painful or inflamed region may temporarily increase local discomfort. Persistent or severe shoulder pain, especially when accompanied by significant swelling, warmth, fever, marked weakness, or loss of movement, should be reviewed rather than assumed to be expected.
What Should Patients Do If Pain Increases After Treatment?
Post-treatment instructions should come from the treating physician because recommendations depend on the joint, procedure, underlying diagnosis, and individual medical history.
In many cases, a short period of relative rest and temporary reduction in strenuous loading may be advised after a joint injection. Some clinicians may also recommend local cooling or other simple measures for temporary discomfort.
The important point is to avoid both extremes. Patients should not immediately return to heavy exercise because they feel relatively well, but they also should not remain inactive for a prolonged period unless there is a medical reason.
Once the early post-treatment period has passed, gradual rehabilitation may be important for restoring strength, mobility, and function.
How Should Patients Interpret Pain After a Stem Cell Injection?
A temporary increase in pain after a stem cell injection can occur and is one of the more commonly reported short-term reactions following intra-articular MSC treatment.
It does not automatically mean the treatment has failed, and it does not prove that the stem cells are working.
Most importantly, the pattern matters. Mild soreness that gradually improves is very different from pain that becomes progressively more severe or occurs with marked swelling, warmth, fever, or substantial loss of movement.
Patients should understand what symptoms are expected after their specific procedure and when they should contact their treating physician.
Frequently Asked Questions
- Is it normal for my knee to hurt more after a stem cell injection?
Temporary soreness, swelling, or stiffness can occur after an intra-articular MSC injection. Published studies identify injection-site pain and swelling among the most common short-term reactions.
- Does more pain mean the stem cells are working?
No. There is no established evidence that a stronger pain reaction predicts a better therapeutic response. Post-injection discomfort and long-term treatment effectiveness should be considered separately.
- How long should post-injection pain last?
There is no universal timeframe because reactions differ between patients, cell products, treatment sites, and procedures. The overall trend is more important. Symptoms should generally improve rather than progressively worsen.
- When should worsening pain be checked by a doctor?
Medical review is important when pain is severe, progressively worsening, associated with substantial swelling or warmth, significantly restricts movement or weight bearing, or occurs with fever or systemic illness.
- Can swelling cause more pain after the injection?
Yes. Temporary joint swelling or effusion can increase pressure and stiffness within the joint, which may make movement more uncomfortable until the local reaction settles.
Related Reading
- Why Rehabilitation Matters After Stem Cell Therapy
- Stem Cell Therapy: Benefits, Limitations, and Realistic Expectations
About EDNA Wellness
EDNA Wellness is a surgeon-led regenerative medicine center in Bangkok, specializing in orthopedic and neurological conditions using Umbilical Cord Derived Mesenchymal Stem Cells (UC-MSCs).
All cases are reviewed by orthopedic surgeons and neurosurgeons, with a focus on clinical indication, patient safety, and realistic treatment expectations. Stem cell therapy is recommended selectively, and alternative treatments are considered when more appropriate.
For more information or to book a consultation:
LINE: @ednawellness
WhatsApp: +66 (0) 64 505 5599
Website: www.ednawellness.com
References
- Intra-articular procedures and associated septic arthritis: A mini-review. 2025. https://pubmed.ncbi.nlm.nih.gov/39798919/
- Matas J, Orrego M, Amenábar D, et al. Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial. Stem Cells Translational Medicine. 2019. https://pubmed.ncbi.nlm.nih.gov/30592390/
- Three intra-articular injections of allogeneic umbilical cord-derived mesenchymal stromal cells in knee osteoarthritis: a phase-I clinical trial. 2026. https://pubmed.ncbi.nlm.nih.gov/41757831/
- Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials. 2026. https://pubmed.ncbi.nlm.nih.gov/41863718/
- Riggle BA, Palmer J, Scott A, et al. Complications of Stem Cell-Based Injections for Knee Osteoarthritis: A Systematic Review. 2024. https://pubmed.ncbi.nlm.nih.gov/39564419/